The Official Journal of Neuroscience Research Center, IUMS
Image Credit:Thrita
Health-Boosting Effects of Aerobic Exercise Training and Berberine on Diabetes: A Brief Overview
Authors
Abstract
Type 2 diabetes is one of the most important metabolic disorders that affect lifestyle. Accordingly, studies have shown that lifestyle changes, especially increasing daily physical activity, can prevent diabetes and help people with the disease through various mechanisms. On the other hand, the use of medicinal plants due to having various phytochemical compounds, each of which has healing properties, can be considered a helpful method in preventing and treating diabetes complications. One of the phytochemical compounds used as an effective substance in the treatment of diabetes is an alkaloid called Berberine. Berberine has been used in traditional medicine to lower blood glucose, and new studies in both in vivo and in vitro conditions have confirmed the diabetic effect of Berberine. Receiving increased energy metabolism, increased glucose and fatty acid uptake by peripheral tissues, improving lipid profile, reducing inflammatory mediators, increasing antioxidant capacity are common mechanisms that aerobic exercise and Berberine exert their beneficial effects in diabetes. In the present study, the effect of aerobic exercise, Berberine, and its combination on diabetes markers have been investigated considering the beneficial effects of aerobic exercise and Berberine in diabetes.
Footnotes
Authors' Contribution: Mohammad Ali Azarbayjani planned and coordinated the study. Maghsoud Peeri, Parvin Farzanegi, and Seyed Ali Hosseini analyzed the data and prepared the manuscript. Hossein Heidari performed the sample collection, identified and enrolled all participants, and collected all the clinical data. All authors critically reviewed the manuscript and approved the submitted version.
Conflict of Interests: The authors of this article declare that there is no conflict of interest.
Funding/Support: No funding was received for this study.
References
- 1.Anderson E, Durstine J. Physical activity, exercise, and chronic diseases: A brief review. Sports Med Health Sci. 2019;1(1):3-10. https://doi.org/10.1016/j.smhs.2019.08.006.
- 2.Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol. 2012;2(2):1143-211. [PubMed ID: 23798298]. [PubMed Central ID: PMC4241367]. https://doi.org/10.1002/cphy.c110025.
- 3.Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451-62. [PubMed ID: 33239350]. [PubMed Central ID: PMC7719906]. https://doi.org/10.1136/bjsports-2020-102955.
- 4.Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334-59. [PubMed ID: 21694556]. https://doi.org/10.1249/MSS.0b013e318213fefb.
- 5.Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380(9838):219-29. [PubMed ID: 22818936]. [PubMed Central ID: PMC3645500]. https://doi.org/10.1016/S0140-6736(12)61031-9.
- 6.Pedersen BK, Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25 Suppl 3:1-72. [PubMed ID: 26606383]. https://doi.org/10.1111/sms.12581.
- 7.Barker K, Eickmeyer S. Therapeutic Exercise. Med Clin North Am. 2020;104(2):189-98. [PubMed ID: 32035563]. https://doi.org/10.1016/j.mcna.2019.10.003.
- 8.Stefani L, Galanti G. Physical Exercise Prescription in Metabolic Chronic Disease. Adv Exp Med Biol. 2017;1005:123-41. [PubMed ID: 28916931]. https://doi.org/10.1007/978-981-10-5717-5_6.
- 9.Dhandapani R, Sabna B. Phytochemical constituents of some Indian medicinal plants. Anc Sci Life. 2008;27(4):1-8. [PubMed ID: 22557280]. [PubMed Central ID: PMC3330865].
- 10.Arora I, Sharma M, Tollefsbol TO. Combinatorial Epigenetics Impact of Polyphenols and Phytochemicals in Cancer Prevention and Therapy. Int J Mol Sci. 2019;20(18). [PubMed ID: 31540128]. [PubMed Central ID: PMC6769666]. https://doi.org/10.3390/ijms20184567.
- 11.Shin HJ, Hwang KA, Choi KC. Antitumor Effect of Various Phytochemicals on Diverse Types of Thyroid Cancers. Nutrients. 2019;11(1). [PubMed ID: 30634497]. [PubMed Central ID: PMC6356543]. https://doi.org/10.3390/nu11010125.
- 12.Blekkenhorst LC, Sim M, Bondonno CP, Bondonno NP, Ward NC, Prince RL, et al. Cardiovascular Health Benefits of Specific Vegetable Types: A Narrative Review. Nutrients. 2018;10(5). [PubMed ID: 29751617]. [PubMed Central ID: PMC5986475]. https://doi.org/10.3390/nu10050595.
- 13.Sham TT, Chan CO, Wang YH, Yang JM, Mok DK, Chan SW. A review on the traditional Chinese medicinal herbs and formulae with hypolipidemic effect. Biomed Res Int. 2014;2014:925302. [PubMed ID: 25110708]. [PubMed Central ID: PMC4109135]. https://doi.org/10.1155/2014/925302.
- 14.Salehi B, Ata A, V. Anil Kumar N, Sharopov F, Ramirez-Alarcon K, Ruiz-Ortega A, et al. Antidiabetic Potential of Medicinal Plants and Their Active Components. Biomolecules. 2019;9(10). [PubMed ID: 31575072]. [PubMed Central ID: PMC6843349]. https://doi.org/10.3390/biom9100551.
- 15.Meng X, Tang GY, Liu PH, Zhao CJ, Liu Q, Li HB. Antioxidant activity and hepatoprotective effect of 10 medicinal herbs on CCl4-induced liver injury in mice. World J Gastroenterol. 2020;26(37):5629-45. [PubMed ID: 33088157]. [PubMed Central ID: PMC7545387]. https://doi.org/10.3748/wjg.v26.i37.5629.
- 16.Yatoo MI, Gopalakrishnan A, Saxena A, Parray OR, Tufani NA, Chakraborty S, et al. Anti-Inflammatory Drugs and Herbs with Special Emphasis on Herbal Medicines for Countering Inflammatory Diseases and Disorders - A Review. Recent Pat Inflamm Allergy Drug Discov. 2018;12(1):39-58. [PubMed ID: 29336271]. https://doi.org/10.2174/1872213X12666180115153635.
- 17.Tillhon M, Guaman Ortiz LM, Lombardi P, Scovassi AI. Berberine: new perspectives for old remedies. Biochem Pharmacol. 2012;84(10):1260-7. [PubMed ID: 22842630]. https://doi.org/10.1016/j.bcp.2012.07.018.
- 18.Imenshahidi M, Hosseinzadeh H. Berberine and barberry (Berberis vulgaris): A clinical review. Phytother Res. 2019;33(3):504-23. [PubMed ID: 30637820]. https://doi.org/10.1002/ptr.6252.
- 19.Winnick JJ, Sherman WM, Habash DL, Stout MB, Failla ML, Belury MA, et al. Short-term aerobic exercise training in obese humans with type 2 diabetes mellitus improves whole-body insulin sensitivity through gains in peripheral, not hepatic insulin sensitivity. J Clin Endocrinol Metab. 2008;93(3):771-8. [PubMed ID: 18073312]. [PubMed Central ID: PMC2266960]. https://doi.org/10.1210/jc.2007-1524.
- 20.Galbo H, Tobin L, van Loon LJ. Responses to acute exercise in type 2 diabetes, with an emphasis on metabolism and interaction with oral hypoglycemic agents and food intake. Appl Physiol Nutr Metab. 2007;32(3):567-75. [PubMed ID: 17510698]. https://doi.org/10.1139/H07-029.
- 21.Matinhomaee H, Banaei J, Azarbayjani MA, Zolaktaf V. Effects of 12-week high-intensity interval training on plasma visfatin concentration and insulin resistance in overweight men. J Exerc Sci Fit. 2014;12(1):20-5. https://doi.org/10.1016/j.jesf.2014.01.001.
- 22.Azarbayjani MA, Abedi B, Peeri M, Rasaee MJ, Stannard SR. Effects of combined aerobic and resistant training on lipid profile and glycemic control in sedentary men. Int Med J. 2014;21(2):132-6.
- 23.Houmard JA, Tanner CJ, Slentz CA, Duscha BD, McCartney JS, Kraus WE. Effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol (1985). 2004;96(1):101-6. [PubMed ID: 12972442]. https://doi.org/10.1152/japplphysiol.00707.2003.
- 24.Behboudi L, Azarbayjani MA, Aghaalinejad H, Salavati M. Effects of aerobic exercise and whole body vibration on glycaemia control in type 2 diabetic males. Asian J Sports Med. 2011;2(2):83-90. [PubMed ID: 22375223]. [PubMed Central ID: PMC3289205]. https://doi.org/10.5812/asjsm.34789.
- 25.Wang Y, Simar D, Fiatarone Singh MA. Adaptations to exercise training within skeletal muscle in adults with type 2 diabetes or impaired glucose tolerance: a systematic review. Diabetes Metab Res Rev. 2009;25(1):13-40. [PubMed ID: 19143033]. https://doi.org/10.1002/dmrr.928.
- 26.Chudyk A, Petrella RJ. Effects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis. Diabetes Care. 2011;34(5):1228-37. [PubMed ID: 21525503]. [PubMed Central ID: PMC3114506]. https://doi.org/10.2337/dc10-1881.
- 27.Melo LC, Dativo-Medeiros J, Menezes-Silva CE, Barbosa FT, de Sousa-Rodrigues CF, Rabelo LA. Physical Exercise on Inflammatory Markers in Type 2 Diabetes Patients: A Systematic Review of Randomized Controlled Trials. Oxid Med Cell Longev. 2017;2017:8523728. [PubMed ID: 28400914]. [PubMed Central ID: PMC5376457]. https://doi.org/10.1155/2017/8523728.
- 28.Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, et al. The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives. Eur Cardiol. 2019;14(1):50-9. [PubMed ID: 31131037]. [PubMed Central ID: PMC6523054]. https://doi.org/10.15420/ecr.2018.33.1.
- 29.Al-Shukaili A, Al-Ghafri S, Al-Marhoobi S, Al-Abri S, Al-Lawati J, Al-Maskari M. Analysis of inflammatory mediators in type 2 diabetes patients. Int J Endocrinol. 2013;2013:976810. [PubMed ID: 23762057]. [PubMed Central ID: PMC3671680]. https://doi.org/10.1155/2013/976810.
- 30.Abd El-Kader S, Gari A, Salah El-Den A. Impact of moderate versus mild aerobic exercise training on inflammatory cytokines in obese type 2 diabetic patients: a randomized clinical trial. Afr Health Sci. 2013;13(4):857-63. [PubMed ID: 24940305]. [PubMed Central ID: PMC4056484]. https://doi.org/10.4314/ahs.v13i4.1.
- 31.Salamat KM, Azarbayjani MA, Yusof A, Dehghan F. The response of pre-inflammatory cytokines factors to different exercises (endurance, resistance, concurrent) in overweight men. Alexandria J Med. 2019;52(4):367-70. https://doi.org/10.1016/j.ajme.2015.12.007.
- 32.Kallantar N, Fatolahi H. Decrease of plasma TNF-α and CRP levels in response to postexhaust resistance training and vitamin D supplementation in overweight healthy women. Romanian J Diabetes, Nutr Metab Dis. 2020;27(4):349-56.
- 33.Goh J, Goh KP, Abbasi A. Exercise and Adipose Tissue Macrophages: New Frontiers in Obesity Research? Front Endocrinol (Lausanne). 2016;7:65. [PubMed ID: 27379017]. [PubMed Central ID: PMC4905950]. https://doi.org/10.3389/fendo.2016.00065.
- 34.Woods JA, Vieira VJ, Keylock KT. Exercise, inflammation, and innate immunity. Immunol Allergy Clin North Am. 2009;29(2):381-93. [PubMed ID: 19389588]. https://doi.org/10.1016/j.iac.2009.02.011.
- 35.Manna P, Jain SK. Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies. Metab Syndr Relat Disord. 2015;13(10):423-44. [PubMed ID: 26569333]. [PubMed Central ID: PMC4808277]. https://doi.org/10.1089/met.2015.0095.
- 36.Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A, et al. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev. 2011;7(5):313-24. [PubMed ID: 21838680]. https://doi.org/10.2174/157339911797415585.
- 37.Krause M, Rodrigues-Krause J, O'Hagan C, Medlow P, Davison G, Susta D, et al. The effects of aerobic exercise training at two different intensities in obesity and type 2 diabetes: implications for oxidative stress, low-grade inflammation and nitric oxide production. Eur J Appl Physiol. 2014;114(2):251-60. [PubMed ID: 24233244]. https://doi.org/10.1007/s00421-013-2769-6.
- 38.Nojima H, Watanabe H, Yamane K, Kitahara Y, Sekikawa K, Yamamoto H, et al. Effect of aerobic exercise training on oxidative stress in patients with type 2 diabetes mellitus. Metabolism. 2008;57(2):170-6. [PubMed ID: 18191045]. https://doi.org/10.1016/j.metabol.2007.08.021.
- 39.Vinetti G, Mozzini C, Desenzani P, Boni E, Bulla L, Lorenzetti I, et al. Supervised exercise training reduces oxidative stress and cardiometabolic risk in adults with type 2 diabetes: a randomized controlled trial. Sci Rep. 2015;5:9238. [PubMed ID: 25783765]. [PubMed Central ID: PMC4363871]. https://doi.org/10.1038/srep09238.
- 40.Cooper CE, Vollaard NB, Choueiri T, Wilson MT. Exercise, free radicals and oxidative stress. Biochem Soc Trans. 2002;30(2):280-5. [PubMed ID: 12023865].
- 41.Golbidi S, Badran M, Laher I. Antioxidant and anti-inflammatory effects of exercise in diabetic patients. Exp Diabetes Res. 2012;2012:941868. [PubMed ID: 22007193]. [PubMed Central ID: PMC3191828]. https://doi.org/10.1155/2012/941868.
- 42.Wycherley TP, Brinkworth GD, Noakes M, Buckley JD, Clifton PM. Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes. Diabetes Obes Metab. 2008;10(11):1062-73. [PubMed ID: 18435772]. https://doi.org/10.1111/j.1463-1326.2008.00863.x.
- 43.Farzanegi P, Dana A, Ebrahimpoor Z, Asadi M, Azarbayjani MA. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. Eur J Sport Sci. 2019;19(7):994-1003. [PubMed ID: 30732555]. https://doi.org/10.1080/17461391.2019.1571114.
- 44.Sallam N, Laher I. Exercise Modulates Oxidative Stress and Inflammation in Aging and Cardiovascular Diseases. Oxid Med Cell Longev. 2016;2016:7239639. [PubMed ID: 26823952]. [PubMed Central ID: PMC4707375]. https://doi.org/10.1155/2016/7239639.
- 45.Atalay M, Laaksonen DE. Diabetes, oxidative stress and physical exercise. J Sports Sci Med. 2002;1(1):1-14. [PubMed ID: 24672266]. [PubMed Central ID: PMC3957575].
- 46.Fatolahi H, Azarbayjani MA, Peeri M, Homaee HM. The effect of exercise on paraoxonase-1 activity and lipid profile in obesity and insulin resistance conditions. Iran J Diabetes Obes. 2017;9(1):82-93.
- 47.Jin Y, Khadka DB, Cho WJ. Pharmacological effects of berberine and its derivatives: a patent update. Expert Opin Ther Pat. 2016;26(2):229-43. [PubMed ID: 26610159]. https://doi.org/10.1517/13543776.2016.1118060.
- 48.Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, et al. Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics. Theranostics. 2019;9(7):1923-51. [PubMed ID: 31037148]. [PubMed Central ID: PMC6485276]. https://doi.org/10.7150/thno.30787.
- 49.Ma H, Hu Y, Zou Z, Feng M, Ye X, Li X. Antihyperglycemia and Antihyperlipidemia Effect of Protoberberine Alkaloids From Rhizoma Coptidis in HepG2 Cell and Diabetic KK-Ay Mice. Drug Dev Res. 2016;77(4):163-70. [PubMed ID: 27045983]. https://doi.org/10.1002/ddr.21302.
- 50.Chang W, Chen L, Hatch GM. Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies. Biochem Cell Biol. 2015;93(5):479-86. [PubMed ID: 25607236]. https://doi.org/10.1139/bcb-2014-0107.
- 51.Sun H, Wang N, Cang Z, Zhu C, Zhao L, Nie X, et al. Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats. Obes Facts. 2016;9(6):365-78. [PubMed ID: 27898425]. [PubMed Central ID: PMC5644798]. https://doi.org/10.1159/000449507.
- 52.Yu Y, Liu L, Wang X, Liu X, Liu X, Xie L, et al. Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochem Pharmacol. 2010;79(7):1000-6. [PubMed ID: 19945441]. https://doi.org/10.1016/j.bcp.2009.11.017.
- 53.Sogin EM, Anderson P, Williams P, Chen CS, Gates RD. Application of 1H-NMR metabolomic profiling for reef-building corals. PLoS One. 2014;9(10). e111274. [PubMed ID: 25354140]. [PubMed Central ID: PMC4213140]. https://doi.org/10.1371/journal.pone.0111274.
- 54.Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004;10(12):1344-51. [PubMed ID: 15531889]. https://doi.org/10.1038/nm1135.
- 55.Lee S, Lim HJ, Park JH, Lee KS, Jang Y, Park HY. Berberine-induced LDLR up-regulation involves JNK pathway. Biochem Biophys Res Commun. 2007;362(4):853-7. [PubMed ID: 17767919]. https://doi.org/10.1016/j.bbrc.2007.08.060.
- 56.Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-7. [PubMed ID: 18442638]. [PubMed Central ID: PMC2410097]. https://doi.org/10.1016/j.metabol.2008.01.013.
- 57.Li Z, Geng YN, Jiang JD, Kong WJ. Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid Based Complement Alternat Med. 2014;2014:289264. [PubMed ID: 24669227]. [PubMed Central ID: PMC3942282]. https://doi.org/10.1155/2014/289264.
- 58.Wang L, Ma H, Xue Y, Shi H, Ma T, Cui X. Berberine inhibits the ischemia-reperfusion injury induced inflammatory response and apoptosis of myocardial cells through the phosphoinositide 3-kinase/RAC-alpha serine/threonine-protein kinase and nuclear factor-kappaB signaling pathways. Exp Ther Med. 2018;15(2):1225-32. [PubMed ID: 29403554]. [PubMed Central ID: PMC5780743]. https://doi.org/10.3892/etm.2017.5575.
- 59.Yu L, Li Q, Yu B, Yang Y, Jin Z, Duan W, et al. Berberine Attenuates Myocardial Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation Response: Role of Silent Information Regulator 1. Oxid Med Cell Longev. 2016;2016:1689602. [PubMed ID: 26788242]. [PubMed Central ID: PMC4691633]. https://doi.org/10.1155/2016/1689602.
- 60.Chatuphonprasert W, Lao-Ong T, Jarukamjorn K. Improvement of superoxide dismutase and catalase in streptozotocin-nicotinamide-induced type 2-diabetes in mice by berberine and glibenclamide. Pharm Biol. 2013. [PubMed ID: 24188560]. https://doi.org/10.3109/13880209.2013.839714.
- 61.Ezabadi A, Peeri M, Azarbayjani MA, Hosseini SA. The Effects of Resistance Training and Berberine Chloride Supplementation on Oxidative Stress Markers in the Cerebellum Tissue of Diazinon-Poisoned Rats. Middle East Journal of Rehabilitation and Health Studies. 2019;6(3). https://doi.org/10.5812/mejrh.92870.
- 62.Liu W, Liu P, Tao S, Deng Y, Li X, Lan T, et al. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose. Arch Biochem Biophys. 2008;475(2):128-34. [PubMed ID: 18471986]. https://doi.org/10.1016/j.abb.2008.04.022.
- 63.Moghaddam HK, Baluchnejadmojarad T, Roghani M, Khaksari M, Norouzi P, Ahooie M, et al. Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats. Mol Neurobiol. 2014;49(2):820-6. [PubMed ID: 24113841]. https://doi.org/10.1007/s12035-013-8559-7.
- 64.Azizi S, Saghebjoo M, Mohiti- Ardakani J. Reducing Effects of Aerobic Exercise Training Combined with Berberine Chloride Supplementation on the Apoptotic Markers of Kidney in Streptozotocin-Induced Diabetic Male Rats. Middle East J Rehabil Health Stud. 2019;6(4). https://doi.org/10.5812/mejrh.96483.
- 65.Sadighi A, abdi A, Azarbayjani MA, barari A. Response of Some Apoptotic Indices to Six Weeks of Aerobic Training in Streptozotocin-Induced Diabetic Rats. Medical Laboratory Journal. 2021;15(1):33-9. https://doi.org/10.29252/mlj.15.1.33.
- 66.Ramezani J, Azarbayjani MA, Peeri M. Simultaneous Effects of Aerobic Training and Berberine Chloride on Plasma Glucose, IL-6 and TNF-α in Type 1 Diabetic Male Wistar Rats. Nutr Food Sci Res. 2019;6(1):9-16. https://doi.org/10.29252/nfsr.6.1.9.
- 67.Ghorashi SA, Bouri SZ, Azarbayjani MA. Cardiovascular Effects Circular Training (Resistance-Interval) Combined with Berberine in Overweight Elderly Men. Int J Health Stud. 2019;5(2).
Copyright
Copyright © 2021, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Similar Articles
Berberis Fruit Extract and Biochemical Parameters in Patients With Type II Diabetes
Moazezi Z, Qujeq D. Berberis Fruit Extract and Biochemical Parameters in Patients With Type II Diabetes. Jundishapur J Nat Pharm Prod. 2014;9(2):e13490. doi: https://doi.org/10.17795/jjnpp-13490
Effects of Aerobic Exercise Combined with Berberine Chloride Hydrate Supplementation on the Mitochondrial Biogenesis of Cardiac Muscles in Diabetic Male Rats
Mehrpuya E, Keshavarz S, Banitalebi E, Naghizadeh H, Ramezani J. Effects of Aerobic Exercise Combined with Berberine Chloride Hydrate Supplementation on the Mitochondrial Biogenesis of Cardiac Muscles in Diabetic Male Rats. Zahedan J Res Med Sci. 2023;25(4):e132725. doi: https://doi.org/10.5812/zjrms-132725
The Effects of Active Ingredients of Barberry Root (Berberine) on Glycemic Control and Insulin Resistance in Type 2 Diabetic Patients
Rashidi H, Namjoyan F, Mehraban Z, Zakerkish M, Ghaderian SB, et al. The Effects of Active Ingredients of Barberry Root (Berberine) on Glycemic Control and Insulin Resistance in Type 2 Diabetic Patients. Jundishapur J Nat Pharm Prod. 2018;13(1):e64180. doi: https://doi.org/10.5812/jjnpp.64180
Reducing Effects of Aerobic Exercise Training Combined with Berberine Chloride Supplementation on the Apoptotic Markers of Kidney in Streptozotocin-Induced Diabetic Male Rats
Azizi S, Saghebjoo M, Mohiti- Ardakani J. Reducing Effects of Aerobic Exercise Training Combined with Berberine Chloride Supplementation on the Apoptotic Markers of Kidney in Streptozotocin-Induced Diabetic Male Rats. Middle East J Rehabil Health Stud. 2019;6(4):e96483. doi: https://doi.org/10.5812/mejrh.96483
The Effects of Berberis vulgaris Fruit Extract on Serum Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients
Shidfar F, Ebrahimi SS, Hosseini S, Heydari I, Shidfar S, et al. The Effects of Berberis vulgaris Fruit Extract on Serum Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients. Iran J Pharm Res. 2012;11(2):e125856. doi: https://doi.org/10.22037/ijpr.2012.1155
- Scopus by DOI: 0
Last Update: 2 days ago
- Scopus by Title: 0
Last Update: 2 days ago
- Scopus by Title (Ref): 1
Last Update: 2 days ago
- CrossRef: 1
Last Update: 17 hours ago